Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study on Sequential Infusion Versus Concomitant Infusion of Ceftazidime-avibactam Combined With Aztreonam for the Treatment of Metallo-β-lactamase-producing Carbapenem-resistant Gram-negative Bacterial Infections.

NCT07478484 is registered in ClinicalTrials.gov with Jing Zhou as lead sponsor.

NCT NCT07478484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07478484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study on Sequential Infusion Versus Concomitant Infusion of Ceftazidime-avibactam Combined With Aztreonam for the Treatment of Metallo-β-lactamase-producing Carbapenem-resistant Gram-negative Bacterial Infections.
Lead sponsor
Jing Zhou
Phase
Phase 4
Overall status
Recruiting
Start date
March 31, 2026
Completion date
January 31, 2028
Enrollment
144 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aztreonam, carbapenem-resistant, ceftazidime-avibactam, gram-negative bacterial infection, metallo-β-lactamase-producing